<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25364200</article-id><article-id pub-id-type="pmc">4213969</article-id><article-id pub-id-type="publisher-id">AYU-35-50</article-id><article-id pub-id-type="doi">10.4103/0974-8520.141924</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Management of <italic>Vyanga</italic> (facial melanosis) with <italic>Arjuna Twak Lepa</italic> and <italic>Panchanimba Churna</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Angadi</surname><given-names>Savita S.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Gowda</surname><given-names>Sumitra T.</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">P.G. Department of Shalakya Tantra, Shri J.G.C.H.Society's Ayurvedic Medical College, Ghataprabha, Belgaum, India</aff><aff id="aff2"><label>1</label>Department of P.G. Studies in Shalakya Tantra, Government Ayurvedic Medical College, Bengaluru, Karnataka, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Prof. Savita S. Angadi, P.G. Department of Shalakya Tantra, Shri J.G.C.H.Society's Ayurvedic Medical College, Ghataprabha, Belgaum - 591 306, E-mail: <email xlink:href="savita.angadi@yahoo.com">savita.angadi@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2014</year></pub-date><volume>35</volume><issue>1</issue><fpage>50</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p><italic>Vyanga</italic> is one of the <italic>Kshudraroga</italic>, characterized by the presence of <italic>Niruja</italic> (painless) and Shavavarna <italic>Mandalas</italic> (bluish-black patches) on face. It is one of the most common diseases as regards the face is concerned. On the basis of clinical features, it can be compared with facial melanosis, one of the hyper pigmented disorders. Drugs with <italic>Rakta Prasadaka</italic>, <italic>Twak Prasadaka</italic> and <italic>Varnyakara</italic> properties are helpful in the management of <italic>Vyanga</italic>, that pacifies aggregated <italic>Doshas</italic> and help in <italic>Raktashodhana</italic> (blood purification).</p></sec><sec id="st2"><title>Aim:</title><p>To evaluate the efficacy of <italic>Arjunatwak Lepa</italic> and <italic>Panchanimba Churna</italic> in <italic>Vyanga</italic>.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>In this study, the trial drugs used were <italic>Arjunatwak Churna</italic> for Lepa (tropical application) and <italic>Panchanimba Churna</italic> for oral administration. A total 30 patients of <italic>Vyanga</italic> were selected from outpatient department and inpatient department of <italic>Shalakya Tantra</italic> Department and allotted randomly in two groups. In group-A, the patients were treated with external application of <italic>Arjunatwak Churna</italic> and <italic>Madhu</italic> for 21 days, while in group-B, patients received <italic>Panchanimba Churna</italic> orally for 21 days in addition to <italic>Arjunatwak Churna</italic> for Lepa. Effect of therapy on chief complaint i.e., bluish-black pigmentation in Group A was 60% relief, while in Group B 80% relief was found.</p></sec><sec id="st4"><title>Conclusion:</title><p>The clinical study has shown that combined therapy gives better results than topical treatment.</p></sec></abstract><kwd-group><kwd><italic>Arjunatwak Churna</italic></kwd><kwd>facial melanosis</kwd><kwd><italic>Panchanimba Churna</italic></kwd><kwd><italic>Vyanga</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Smooth and glowing complexion of the face increases the beauty of a person and also gives self-confidence. <italic>Vyanga</italic> is a disease, which decreases the glowing complexion of the face and affects the skin. Among many diseases concerned with cosmetic values, <italic>Vyanga</italic> is common disease known to us from thousands of years. Though it is considered as Kshudra Roga (minor disease), has got a major importance as a cosmetic problem in the society. It is characterized by the presence of <italic>Niruja</italic> (painless), <italic>Tanu</italic> (thin) and Shavavarna <italic>Mandalas</italic> (bluish-black patches) on face,[<xref rid="ref1" ref-type="bibr">1</xref>] occurs due to vitiation of <italic>Vata</italic>, Pitta followed by <italic>Rakta Dosha</italic>.[<xref rid="ref2" ref-type="bibr">2</xref>] Treating this condition has become a problem, since safe drugs are not available for long-term therapy.</p><p>In modern medical science, topical steroids have been described in the management of facial melanosis.[<xref rid="ref3" ref-type="bibr">3</xref>] However, the topical steroids are not completely free from adverse effects such as irritation, rashes.[<xref rid="ref4" ref-type="bibr">4</xref>] Apart from this, generally the topical steroids are expensive and sometimes poor patients cannot afford this treatment. Hence there is a need to search better methods of management in facial melanosis considering the above drawbacks.</p><p>Ayurveda mentions a good number of medicines for skin care. Massage with oils, application of paste of medicines etc., makes the face smooth, soft and glowing.[<xref rid="ref5" ref-type="bibr">5</xref>] In addition to this, bloodletting is also described.[<xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Drugs having <italic>Kusthaghna</italic>, <italic>Kandughna</italic>, <italic>Raktashodhaka</italic>, <italic>Twak Prasadaka</italic> and <italic>Varnyakara</italic> properties are helpful in the management and can produce cutaneous depigmentation that remove the blackish discoloration of skin.</p><p>Considering these points, <italic>Arjunatwak Churna</italic> was selected for <italic>Lepa</italic>[<xref rid="ref7" ref-type="bibr">7</xref>] and <italic>Panchanimba Churna</italic> was selected for oral medication as these preparations have <italic>Kusthaghna</italic>, <italic>Kandughna</italic>, <italic>Raktashodhaka</italic>, <italic>Twak Prasadaka</italic> and <italic>Varnyakara</italic> properties.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Source of data</title><p>Patients, fulfilling the clinical criteria of <italic>Vyanga</italic> were randomly selected irrespective of their sex, religion, occupation, etc., from out-patient department and inpatient department sections of the Department of Shalakya Tantra, S.J.I.I.M Bangalore, Karnataka. The study was cleared by the Institutional Ethics Committee (vide letter no.: GAMC / IEC / Shalakya / 11.01.2000 / 11). Written consent was taken from each patient willing to participate before starting the study.</p></sec><sec id="sec2-2"><title>Inclusion criteria</title><p>
<list list-type="order"><list-item><p>Age group: 15-45 years</p></list-item><list-item><p>Chronicity less than 5 years</p></list-item><list-item><p>Shavavarnayukta, <italic>Niruja Mandalas</italic> present over the face.</p></list-item></list>
</p></sec><sec id="sec2-3"><title>Exclusion criteria</title><p>Any specific disease underlying as the cause of <italic>Vyanga</italic> like,</p><p>
<list list-type="order"><list-item><p>Inflammatory pigmentation</p></list-item><list-item><p>Malignant melanoma</p></list-item><list-item><p>Acne Vulgaris were excluded from the study.</p></list-item></list>
</p><sec id="sec3-1"><title>Investigations</title><p>Routine investigations of blood, urine and stool were carried out before treatment to rule out any systemic diseases.</p></sec><sec id="sec3-2"><title>Arjuna Twak Churna and Panchanimba Churna preparation</title><p><italic>Arjuna Twak</italic> Churna and <italic>Panchanimba Churna</italic>[<xref rid="ref8" ref-type="bibr">8</xref>] were prepared according to the standard method of preparation of Churna, in the pharmacy of GAMC Bangalore. The ingredients of <italic>Panchanimba Churna</italic> are depicted at <xref ref-type="table" rid="T1">Table 1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Ingredients of <italic>Panchanimba Churna</italic></p></caption><graphic xlink:href="AYU-35-50-g001"/></table-wrap></sec></sec><sec id="sec2-4"><title>Grouping and treatment schedule</title><p>A total of 30 patients were registered and divided in two groups, comprising 15 patients each in Group A and Group B.</p><sec id="sec3-3"><title>Group A</title><p>The patients under this group were treated with Lepa of <italic>Arjunatwak Churna</italic> along with <italic>Madhu</italic> for 30 min, once daily for 21 days.</p></sec><sec id="sec3-4"><title>Group B</title><p>The patients under this group were treated with Lepa of <italic>Arjunatwak Churna</italic> along with <italic>Madhu</italic> for 30 min, once daily and internal medication of <italic>Panchanimba Churna</italic> in the dose of 4 g for three times daily with water after food for 21 days.</p></sec><sec id="sec3-5"><title>Follow-up</title><p>Patients were asked to attend the OPD on alternate weeks for follow-up for a period of 90 days.</p></sec></sec></sec><sec id="sec1-3"><title>Observations and Results</title><p>Maximum number of patients (56.66%) were in the age group of 26-35 years. Majority of the patients were females (90%). Most of the patients (63.33%) were from middle class. Nearly 56.67% of patients have patches on cheeks, nose and fore head. In 43.33% of patients, the color of patch was dark brown, in 33.33% it was blue-black and in 23.34% of patients it was light brown in color.</p><sec id="sec2-5"><title>Pattern of changes in the color of <italic>Mandalas</italic> with the treatment in group A</title><p>In Group A, before treatment, in three patients the <italic>Mandalas</italic> were blue black colored, in eight patients the <italic>Mandalas</italic> were dark brown colored and in four patients the <italic>Mandalas</italic> were light brown colored. On 7<sup>th</sup> day of observation, in three patients the color of <italic>Mandalas</italic> became to bluish black, in seven patients the color became to dark brown, in four patients, it was light brown and one patient attained the normal skin color. On 14<sup>th</sup> day of observation, two patients had bluish black colored patches, three patients had dark brown patches, three patients had light brown colored patches and seven patients attained the normal skin color. At the end of the treatment, in two patients the patches were dark brown in color, in four patients the patches were light brown in color and nine patients attained normal skin color.</p><p>In group A, out of 15 patients, 09 patients were cured completely, which was statistically significant at the level of <italic>P</italic> &#x0003c; 0.01. Four patients have shown marked improvement and two patients showed slight improvement. Statistically significant result was obtained in the symptom blackish/brownish patch over the face [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Effect of therapy on chief complaint (bluish-black discoloration of skin)</p></caption><graphic xlink:href="AYU-35-50-g002"/></table-wrap></sec><sec id="sec2-6"><title>Pattern of changes in the color of <italic>Mandalas</italic> with the treatment in group B</title><p>In Group B, before treatment, in seven patients the <italic>Mandalas</italic> were bluish black colored, in five patients the <italic>Mandalas</italic> were dark brown colored and in three patients the <italic>Mandalas</italic> were light brown colored. On 7<sup>th</sup> day of observation, in seven patients the color of <italic>Mandalas</italic> became bluish black, in four patients the color became dark brown, in two patients it became light brown and two patients attained the normal skin color. On 14<sup>th</sup> day of observation, three patients attained bluish black colored patches, two patients had dark brown patches, two patients had light brown colored patches and eight patients attained the normal skin color. At the end of treatment, one patient had dark brown color patches. In two patients, the light brown colored patches were still persisting and 12 patients had attained normal skin color.</p><p>In group B, out of 15 patients, 12 patients had attained normal skin color, which was statistically highly significant at the level of <italic>P</italic> &#x0003c; 0.001, also one patient had mild improvement and two patients have moderate improvement. Statistically significant result was obtained in the symptom bluish-black patch over the face [<xref ref-type="table" rid="T2">Table 2</xref>].</p><p>The images shows effect of the treatment in one of the patients of Group B [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Before treatment</p></caption><graphic xlink:href="AYU-35-50-g003"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>After treatment</p></caption><graphic xlink:href="AYU-35-50-g004"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p><italic>Vyanga</italic> is explained as a <italic>Kshudra Roga</italic> in Ayurveda. While describing the etiological factors of <italic>Vyanga</italic>, Acharya has given special emphasis towards psychological factors like <italic>Krodha</italic> (anger), <italic>Shoka</italic> (grief) and <italic>Shrama</italic> (exhaustion), which are commonly found in most of the patients. In Samprapti of <italic>Vyanga</italic>, Acharya Charaka has mentioned that the aggravation of <italic>Pitta</italic> along with <italic>Rakta</italic> is the chief culprit for initiation of the pathology. <italic>Vyanga</italic> is a <italic>Rakta Pradoshaja Vyadhi</italic>,[<xref rid="ref9" ref-type="bibr">9</xref>] hence the very first Dosha affected is <italic>Rakta Dhatu</italic>. <italic>Dosha Prakopaka Hetus</italic> like <italic>Krodha</italic>, <italic>Shoka</italic> and <italic>Shrama</italic> are mainly Tama (<italic>Manasika Dosha</italic>), Pitta and <italic>Vata</italic> (<italic>Shareerika Dosha</italic>) dominance,[<xref rid="ref10" ref-type="bibr">10</xref>] vitiates the <italic>Agni</italic> (<italic>Pitta Dosha</italic>) which resides in <italic>Rasa</italic> and initiates the pathogenesis of <italic>Vyanga</italic>. Here <italic>Ranjaka Pitta</italic> is responsible for the conversion of <italic>Rasa Dhatu</italic> into <italic>Rakta Dhatu</italic> which results in the formation of normal skin color. However due to etiological factors like <italic>Krodha</italic> and <italic>Shoka</italic> mainly <italic>Pitta</italic> vitiation takes place which in turn affects the Jatharagni and normal functioning of <italic>Ranjaka Pitta</italic> i.e., <italic>Varnotpatti</italic>. Based on Ashraya-Ashrayee Bhavas, the derangement of <italic>Pitta Dosha</italic> leads to abnormality of <italic>Rakta Dhatu</italic>. <italic>Shrama</italic> and <italic>Shoka</italic> will lead to <italic>Udana Vata</italic> vitiation. Thus vitiated <italic>Ranjaka Pitta</italic>, <italic>Rakta Dhatu</italic> as well as <italic>Udana Vata</italic> travel in body through <italic>Dhamanis</italic> and get <italic>Sthana Samshraya</italic> in <italic>Mukhagata Twacha</italic> and causes vitiation of <italic>Bhrajaka Pitta</italic> giving rise to discoloration of the skin.</p><sec id="sec2-7"><title>Mode of action of drug</title><p>The mode of action of the drug under trial can be understood on the basis of inherent properties of the drug.</p><p>Rasa of <italic>Arjunatwak</italic> is <italic>Kashaya Rasa</italic>,[<xref rid="ref11" ref-type="bibr">11</xref>] <italic>Gunas</italic> are <italic>Laghu</italic>, <italic>Ruksha</italic>, <italic>Veerya</italic> is <italic>Sheeta</italic> and mainly having <italic>Pitta Shamaka</italic> and <italic>Rakta Prasadaka</italic> properties. With property of <italic>Kashaya Rasa</italic>, it will encounters <italic>Pitta</italic> and <italic>Rakta Dosha</italic>. The <italic>Kashaya Rasa</italic> removes the <italic>Twak Vaivarnyata</italic> and helps to attain the normal skin color.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref>] Due to <italic>Sheeta Veerya</italic> it encounters the <italic>Pitta Dosha</italic>. <italic>Prasadana</italic> property of <italic>Sheeta Veerya</italic> also helps to purify the accumulated <italic>Doshas</italic> in <italic>Vyanga</italic>. The <italic>Rakta Prasadaka</italic> and <italic>Twak Prasadaka</italic> actions of <italic>Arjuna</italic> help to pacify the <italic>Sanchita Doshas</italic> locally. In <italic>Panchnimba</italic> Churna almost all drugs like <italic>Nimba</italic>, <italic>Bakuchi</italic>[<xref rid="ref14" ref-type="bibr">14</xref>] <italic>Araghwadha</italic>, <italic>Haridra</italic>, <italic>Chakramarda</italic>, <italic>Bhallataka</italic> etc., are having <italic>Rakta Prasadaka</italic> and <italic>Twak Doshahara</italic> properties. In <italic>Panchanimba Churna</italic> the main ingredient is <italic>Nimba</italic> that have <italic>Tikta</italic>, <italic>Kashaya Rasa</italic> and <italic>Laghu</italic>, <italic>Snigdha</italic> properties by which <italic>Pitta Shamaka</italic> action can be observed. <italic>Aragwadha</italic>[<xref rid="ref15" ref-type="bibr">15</xref>] <italic>Amalaki</italic>[<xref rid="ref16" ref-type="bibr">16</xref>] <italic>Maricha</italic>, <italic>Nimba</italic> and <italic>Haridra</italic>[<xref rid="ref17" ref-type="bibr">17</xref>] are having <italic>Kusthaghna</italic> and <italic>Kandughna</italic> properties by which possibly significant efficacy was observed.</p></sec></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>Both trial drugs showed encouraging results. <italic>Arjuna Twak</italic> along with <italic>Madhu</italic> has not shown any skin reactions, so it could be used safely. From the observations and results of this study, it can be concluded that <italic>Arjuna Twak Lepa</italic> along with <italic>Panchanimba Churna</italic> have provided better results in hyperpigmentation of the patches seen in cases of <italic>Vyanga</italic>.</p></sec></body><back><ack><title>Acknowledgments</title><p>The author would like to express sincere thanks to Prof. Sumitra T. Gowda M.D (AYU), for her constant support and suggestions.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Kaviraj Ambikadatta Shastri</surname></name></person-group><article-title>Sushruta. Sushruta Samhita, Nidana Sthana, <italic>Kshudraroga</italic> Nidana Adhyaya, 13/45-46</article-title><source>Chaukhamba Sanskrit Sansthan, Varanasi</source><year>2003</year><edition>14th ed</edition><fpage>288</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name><name><surname>Charaka</surname></name><name><surname>Dridhabala</surname></name></person-group><person-group person-group-type="editor"><name><surname>Aacharya</surname><given-names>VJ</given-names></name></person-group><article-title>Charaka Samhita, Sutra Sthana, Trishothiya Adhyaya, 18/25</article-title><source>Chaukhamba Prakashan, Varanasi</source><year>2009</year><fpage>107</fpage><comment>Reprint ed</comment></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rook</surname><given-names>A</given-names></name></person-group><article-title>Text Book of Dermatology</article-title><year>1986</year><volume>I</volume><edition>4th ed</edition><publisher-loc>London</publisher-loc><publisher-name>Blackwell Scientific Publications</publisher-name><fpage>670</fpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Satoskar</surname><given-names>RS</given-names></name><name><surname>Bhandarkar</surname><given-names>SB</given-names></name><name><surname>Ainapure</surname><given-names>SS</given-names></name></person-group><article-title>Pharmacology and Pharmaco Theuraputics</article-title><year>1999</year><edition>16th ed</edition><publisher-loc>Sec XIII Mumbai</publisher-loc><publisher-name>Popular Prakashan</publisher-name><fpage>843</fpage><lpage>4</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Yogaratnakara</surname></name></person-group><person-group person-group-type="editor"><name><surname>Bhishagratna Brahmashankar</surname><given-names>Shastri</given-names></name></person-group><article-title><italic>Kshudra Roga</italic> Chikitsa</article-title><source>Chaukhamba Sanskrit Sansthan, Varanasi</source><year>2004</year><edition>8th ed</edition><fpage>283</fpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Chikitsa</surname><given-names>Sthana</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kaviraj Ambikadatta</surname><given-names>Shastri</given-names></name></person-group><article-title><italic>Kshudraroga</italic> Chikitsa Adhyaya, 20/33</article-title><source>Chaukhamba Sanskrit Sansthan, Varanasi</source><year>2003</year><edition>14th ed</edition><fpage>94</fpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Govinda</surname><given-names>Dasaji</given-names></name><name><surname>Bhaishajya</surname><given-names>Ratnavali</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kaviraj Shri Ambikadatta</surname><given-names>Shastri</given-names></name></person-group><article-title><italic>Kshudraroga</italic> Chikitsa, 60/40</article-title><source>Chaukhamba Sanskrit Sansthan, Varanasi</source><year>2002</year><edition>4th ed</edition><fpage>663</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sharngadhara</surname></name><name><surname>Sharngadhara</surname><given-names>Samhita</given-names></name><name><surname>Madhya</surname><given-names>Khanda</given-names></name></person-group><article-title>Churna Kalpana, 6/148-153, Subhodhini Hindi commentary by Prayaga Datta Sharma</article-title><source>Chaukamba Amar Bharati Prakashan, Varanasi</source><year>1987</year><edition>7th ed</edition><fpage>197</fpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name><name><surname>Charaka</surname></name><name><surname>Dridhabala</surname></name><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Sutra</surname><given-names>sthana</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Jadhavaji Trikamji</surname><given-names>Aacharya</given-names></name></person-group><article-title>Vividashitapeeteeya Adhyaya 28/11-12</article-title><source>Chaukhamba Prakashan, Varanasi</source><year>2009</year><fpage>179</fpage><comment>Reprint ed</comment></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Sutrasthana</surname></name></person-group><person-group person-group-type="editor"><name><surname>Kaviraj Ambikadatta</surname><given-names>Shastri</given-names></name></person-group><article-title>Vrana Prashna Adhyaya, 21/19, 21</article-title><source>Chaukhamba Sanskrit Sansthan, Varanasi</source><year>2000</year><volume>91</volume><edition>14th ed</edition></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shastry</surname><given-names>JLN</given-names></name></person-group><article-title>Illustrated Dravyaguna Vijnana</article-title><year>2005</year><volume>II</volume><edition>2nd ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Orientalia</publisher-name><fpage>493</fpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vaghbhata</surname></name><name><surname>Ashtanga</surname><given-names>Sangraha</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Shrikantha</surname><given-names>Murthy</given-names></name></person-group><article-title>Sutrasthana, 18/17</article-title><source>Chaukhamba Orientalia, Varanasi</source><year>2005</year><edition>9th ed</edition><fpage>340</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bhavamishra</surname></name><name><surname>Bhava</surname><given-names>Prakasha</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bhrahma Shankar</surname><given-names>Shastri</given-names></name></person-group><article-title>Mishra Prakaranama/193</article-title><source>Chaukhamba Sanskrit Bhavan, Varanasi</source><year>1999</year><edition>9th ed</edition><fpage>187</fpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Khare</surname><given-names>CP</given-names></name></person-group><article-title>Encyclopedia of Indian Medicinal Plants</article-title><year>2004</year><publisher-loc>New York</publisher-loc><publisher-name>Springer-Verlag</publisher-name><fpage>384</fpage><lpage>6</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>G</given-names></name></person-group><article-title>Dravyaguna Vignyana</article-title><year>2002</year><volume>I</volume><edition>2nd ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Krishnadas Academy</publisher-name><fpage>169</fpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="webpage"><article-title>Phyllanthus_emblica</article-title><date-in-citation>cited 2012 Oct 19</date-in-citation><comment>Available from 
<uri xlink:type="simple" xlink:href="http://en.wikipedia.org/wiki/Phyllanthus_emblica">http://en.wikipedia.org/wiki/Phyllanthus_emblica</uri></comment></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baruah</surname><given-names>MK</given-names></name><name><surname>Choudhary</surname><given-names>PD</given-names></name><name><surname>Sharma</surname><given-names>GC</given-names></name></person-group><article-title>Ethnomedicinal plants used by Khasi tribe of Lachar district, Assam</article-title><source>J Econ Taxon Bot</source><year>2006</year><volume>30</volume><issue>suppl</issue><fpage>110</fpage><lpage>114</lpage></element-citation></ref></ref-list></back></article>